Advisor Group Holdings, Inc. Bio Path Holdings Inc Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$2.99 - $4.17 $11 - $16	-4 Reduced 28.57%	10 $0
Q2 2021 Aug 02, 2021	SELL	$5.13 - $7.63 $8,567 - $12,742	-1,670 Reduced 99.17%	14 $0
Q1 2021 May 13, 2021	BUY	$3.63 - $11.77 $6,062 - $19,655	1,670 Added 11928.57%	1,684 $12,000
Q3 2020 Nov 12, 2020	BUY	$3.85 - $5.5 $15 - $22	4 Added 40.0%	14 $0
Q2 2020 Aug 14, 2020	BUY	$4.15 - $6.04 $41 - $60	10 New	10 $0

Ticker BPTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,160,160
Market Cap $6.37M
Description
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.